Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML
ClinicalTrials.gov study NCT07078591. IPD Sharing: NO. Countries: 1. Publications: 0.
Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT06379360. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess
ClinicalTrials.gov study NCT03356080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00136461. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation
ClinicalTrials.gov study NCT04691648. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03915379. IPD Sharing: YES. Countries: 3. Publications: 0.
Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AML
ClinicalTrials.gov study NCT05716009. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)
ClinicalTrials.gov study NCT01019161. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06852222. IPD Sharing: YES. Countries: 24. Publications: 0.
Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission
ClinicalTrials.gov study NCT00667927. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine
ClinicalTrials.gov study NCT02489929. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML
ClinicalTrials.gov study NCT00195104. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06802315. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible
ClinicalTrials.gov study NCT02261779. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
ClinicalTrials.gov study NCT06652438. IPD Sharing: YES. Countries: 3. Publications: 0.
Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00892190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.
ClinicalTrials.gov study NCT03507842. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05947344. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients
ClinicalTrials.gov study NCT04097470. IPD Sharing: NO. Countries: 4. Publications: 0.
Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02181699. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.